Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial. Quinn, G.R., Hellkamp, A.S., Hankey, G.J., Becker, R.C., Berkowitz, S.D., Breithardt, G., Fava, M., Fox, K.A., Halperin, J.L., Mahaffey, K.W. and Nessel, C.C., 2018. Journal of the American Heart Association, 7(15), p.e008755.